Atlas Trials

Phase II HDM-SPIRE Safety and Efficacy Study

Clinical trial NCT02150343 · COMPLETED

Trial details

NCT number
NCT02150343
Sponsor
Circassia Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rhinoconjunctivitis
Start date
2014-09-01
Primary completion
2017-04-13
Enrollment
715

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.